ID: ALA4291810

Max Phase: Preclinical

Molecular Formula: C19H33N3O8S

Molecular Weight: 463.55

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCCOC(=O)C(C)(C)COS(=O)(=O)ON1C(=O)N2C[C@H]1CC[C@H]2C(N)=O

Standard InChI:  InChI=1S/C19H33N3O8S/c1-4-5-6-7-8-11-28-17(24)19(2,3)13-29-31(26,27)30-22-14-9-10-15(16(20)23)21(12-14)18(22)25/h14-15H,4-13H2,1-3H3,(H2,20,23)/t14-,15+/m1/s1

Standard InChI Key:  DZJAYPFVMXXJBZ-CABCVRRESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 463.55

Molecular Weight (Monoisotopic): 463.1988

AlogP: 1.47

#Rotatable Bonds: 13

Polar Surface Area: 145.54

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 11

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa:

CX LogP: 2.23

CX LogD: 2.23

Aromatic Rings: 0

Heavy Atoms: 31

QED Weighted: 0.32

Np Likeness Score: -0.11

References

1. Gordon EM, Duncton MAJ, Gallop MA..  (2018)  Orally Absorbed Derivatives of the β-Lactamase Inhibitor Avibactam. Design of Novel Prodrugs of Sulfate Containing Drugs.,  61  (22): [PMID:30296086] [10.1021/acs.jmedchem.8b01389]

Source

Source(1):

• Scientific Literature